20/01/2012
Report no. 4/2012
Conclusion of a significant contract in the subsidiary company EMC Piaseczno sp. z o.o. managing St. Anne's Hospital in Piaseczno
Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A. informs about receiving as of 20 January 2012 the contracts concluded with the National Health Fund -the Mazowieckie Voivodeship Branch in Warsaw (the Fund Branch) regarding healthcare services in the scope of hospital treatment and therapeutic rehabilitation for the period from 1 January to 31 December 2012.
Healthcare services referred to hereinabove are provided by St. Anne’s Hospital in Piaseczno managed by the Issuer’s subsidiary company EMC Piaseczno sp. z o.o.
The Issuer informed about the contracts with the Fund Branch concerning rendering services in 2011 in its current reports nos.: 35/2011 of 04.03.2011, 57/2011 of 1.04.2011, 69/2011 of 7.06.2011, 70/2011 of 9.06.2011, 72/2011 of 22.06.2011, 96/2011 of 29.08.2011, 98/2011 of 14.09.2011, 98/2011 K of 15.09.2011 and 103/2011 of 20.10.2011.
The contract for the provision of healthcare services such as hospital treatment, marked as 07R-1-01354-03-01-2011-2013/12 (07-06-03688-12-05/06) concluded on 12 January 2012, is the contract with the highest value.
The Parties to the contract are the Issuer and the National Health Fund- the Mazowieckie Voivodeship Branch in Warsaw (the Fund Branch).
The subject of the contract is the provision of healthcare services such as hospital treatment by the Issuer.
The maximum amount of Fund Branch liability towards the Issuer in the period from 1 January 2012 to 31 December 2012 totals maximally PLN 19,587,744.00.
The Issuer undertook, within the duration of the contract, to conclude a civil liability insurance contract against damages caused in relation to the provision of services.
In the case of non-performance or improper performance of the contract, caused by the Company, the Director of the Fund Branch may impose a contractual penalty.
In the case of writing out prescriptions to unauthorised persons or in unjustified cases, the Fund Branch may impose on the Issuer a contractual penalty amounting to the equivalent of the unjustified refund of the costs of medication made on the basis of prescriptions together with statutory interest calculated from the day of making the refund.
In the case of issuing orders for delivery of medical products which are orthopaedic goods and auxiliary goods fully or partially financed by the Funds to unauthorised persons or in unjustified cases, the Fund Branch may impose on the Issuer a contractual penalty amounting to the equivalent of the unjustified financing together with statutory interest calculated from the day of making the refund. Contractual penalties specified above shall be imposed pursuant to provisions stipulated in General Terms and Conditions of the contracts. The Fund Branch is entitled to claim damages exceeding the value of the contractual penalties.
The contract has been concluded for the period from 1 January 2011 to 31 December 2013 with a possibility of its termination by each party upon a 3-month termination notice. The total Fund Branch liability towards the Company specified in the contract refers to the period from 1 January to 31 December 2012.
Total maximum Fund Branch liability towards the Company for the period from 1 January to 31 December 2012 currently amounts to PLN 19,987,745.60.
A criterion for a contract to be considered significant:
The value of contracts exceeds 10% of the Issuer’s equity capital.